Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
     facebook  twitter
Meeting Details  Printer Version   Meeting Search   Contact Us

Ubiquitin and Signaling (B4)

Organizer(s): Brenda A. Schulman, Tony Hunter, Mark W. Hochstrasser and Claudio A.P. Joazeiro
February 4 - 9, 2007
Big Sky Resort  ·  Big Sky, Montana
Abstract Deadline: October 4, 2006
Late Abstract Deadline: November 2, 2006
Scholarship Deadline: October 4, 2006
Early Registration Deadline: December 4, 2006


Supported by the Director's Fund



This meeting took place in the 2007 season.

For a complete list of the meetings for the upcoming/current season,
see our meeting list, or search for a meeting.
Summary of Meeting
Our understanding of how ubiquitin regulates cellular functions has greatly expanded in the past several years, spurred by discoveries of protein families involved in ubiquitin conjugation and deconjugation, and of nonproteasomal signaling functions for ubiquitin and ubiquitin-related proteins. The first Keystone meeting on Ubiquitin and Signaling, in February 2005, was highly successful, based on both strong attendance and feedback from the participants. The significance and timely nature of the ubiquitination problem is highlighted by the 2004 Nobel Prize in Chemistry honoring pioneers in the field. We anticipate a further explosion in our understanding of ubiquitination over the next few years, and propose a meeting that captures this momentum. Ubiquitin regulates an enormous range of cellular processes. There are almost as many predicted human ubiquitin ligases as protein kinases, and the ubiquitin system has been directly implicated in numerous diseases, including many cancers and neurodegenerative disorders. Many protein domains have recently been associated with ubiquitination, deubiquitination or ubiquitin binding. These are found in several thousand proteins, presenting the challenge to determine their functions and mechanistic links to the ubiquitin system. In addition, the ubiquitin system is now widely recognized as a target for pharmacological intervention in various diseases. The goal of the meeting is to bring together experts from different areas of ubiquitin research as well as experts from other fields that are beginning to be affected by our knowledge of ubiquitin function. We expect that this meeting will foster extensive discussion of ubiquitin system function in both normal and pathological states.

Sunday, February 4
3:00 - 7:30 PM Registration Lower Atrium
7:00 - 8:00 PM Refreshments Lower Atrium
8:00 - 9:00 PM Keynote Address: The Cecile Pickart Memorial Lecture Gallatin
Alfred L. Goldberg, Harvard Medical School
What We've Learned and What We Haven't Learned About Protein Degradation
Monday, February 5
7:00 - 8:00 AM Breakfast Jefferson/ Lake/ Canyon Rooms
8:00 - 11:15 AM Regulation by E3 Ubiquitin Ligases Gallatin/ Madison
* Christopher D. Lima, Memorial Sloan-Kettering Cancer Center
Michael Karin, University of California, San Diego
Crosstalk Between Inflammation Cells and Carcinomas
J. Wade Harper, Harvard Medical School
Genetic Discovery in the Ubiquitin Proteasome Pathway
Claudio A.P. Joazeiro, The Scripps Research Institute
Functional Genomic Analyses of Ubiquitin Ligases
Mark A. Estelle, University of California, San Diego
The F-box Protein TIR1 is a Receptor for the Plant Hormone Auxin
Bruce E. Clurman, Fred Hutchinson Cancer Research Center
Fbw7 at the Crossroads of Cell Division, Growth, and Differentiation
9:20 - 9:40 AM Coffee Break Lower Atrium
11:00 AM - 1:00 PM Poster Setup Jefferson/ Lake/ Canyon Rooms
1:00 - 10:00 PM Poster Viewing Jefferson/ Lake/ Canyon Rooms
4:30 - 5:00 PM Coffee Available Lower Atrium
5:00 - 7:00 PM Signal Transduction by Ubiquitin Conjugation and Deconjugation Gallatin/ Madison
* J. Wade Harper, Harvard Medical School
Vishva M. Dixit, Genentech, Inc.
ATM Mediated Auto-Degradation of the E3 Ubiquitin Ligase COP1 After DNA Damage
René Bernards, Netherlands Cancer Institute
RNAi Screens to Identify Functions of DUBs
Christian D. Schlieker, Whitehead Institute for Biomedical Research
Short Talk: Structure of a Herpesvirus-Encoded Deubiquitinating Enzyme Reveals a New Class of Ubiquitin-Specific Proteases
Paul J. Lehner, Cambridge Institute for Medical Research
Short Talk: Lysine-63 Linked Ubiquitination is Required for Efficient Internalization and Endolysosomal Degradation of Critical Immunoreceptors
7:00 - 8:00 PM Social Hour w/ Lite Bites Gallatin/Lake/Canyon Rooms
7:30 - 10:00 PM Poster Session 1 Jefferson/ Lake/ Canyon Rooms
Tuesday, February 6
7:00 - 8:00 AM Breakfast Jefferson/ Lake/ Canyon Rooms
8:00 - 11:00 AM Ubiquitin-Like Protein Pathways Gallatin/ Madison
* Daniel J. Finley, Harvard University
Ronald T. Hay, University of Dundee
Role of SUMO Modification in the Control of Gene Expression
Christopher D. Lima, Memorial Sloan-Kettering Cancer Center
SUMO: Insights into Ubiquitin and Ubiquitin-Like Protein Conjugation
Frauke Melchior, University of Goettingen
Functions and Regulation of SUMOylation
Jorge A. Ińiguez-Lluhi, University of Michigan
Short Talk: SUMO Modification Regulates Inactivation of the voltage-Gated Potassium Channel KV1.5
Brenda A. Schulman, St. Jude Children's Research Hospital
Structural Insights into Ubiquitin-like Protein Activation
9:20 - 9:40 AM Coffee Break Lower Atrium
11:00 AM - 1:00 PM Poster Setup Jefferson/ Lake/ Canyon Rooms
1:00 - 10:00 PM Poster Viewing Jefferson/ Lake/ Canyon Rooms
4:30 - 5:00 PM Coffee Available Lower Atrium
5:00 - 7:00 PM Regulation of and by the Proteasome and Signalosome Gallatin/ Madison
* Alfred L. Goldberg, Harvard Medical School
Xing Wang Deng, Yale University
Role of the MPN subunits in COP9 signalosome assembly and activity, and their regulatory interaction with Cullin3-based E3 ligases
Ning Zheng, University of Washington
Mechanism of Auxin Perception by the TIR1 F-box Protein
Daniel J. Finley, Harvard University
Regulation of Proteasome Function
Rina Rosenzweig, Israel Institute of Technology
Short Talk: A Mason's Approach to the 19S Proteasome Regulator
7:00 - 8:00 PM Social Hour w/ Lite Bites Gallatin/Lake/Canyon Rooms
7:30 - 10:00 PM Poster Session 2 Jefferson/ Lake/ Canyon Rooms
Wednesday, February 7
7:00 - 8:00 AM Breakfast Jefferson/ Lake/ Canyon Rooms
8:00 - 11:00 AM Ubiquitin and Subcellular Compartments Gallatin/ Madison
* Frauke Melchior, University of Goettingen
Simona Polo, FIRC Institute of Molecular Oncology
Molecular Mechanisms of Coupled Monoubiquitination
Thomas Sommer, Max Delbrück Center for Molecular Medicine
Protein Quality Control by the HRD-Ligase Complex
Mary Ann Osley, University of New Mexico
Interplay between H2B Ubiquitylation and Histone Chaperones during Transcription Elongation
Sylvie Urbé, University of Liverpool
Control of Growth Factor Receptor Dynamics by Reversible Ubiquitination
Vincent Chau, Pennsylvania State University College of Medicine
Short Talk: The Crystal Structure of a RING-Ubc7 Fusion Reveals a Mechanism for the Activation of a Ubiquitin-Conjugating Enzyme
9:20 - 9:40 AM Coffee Break Lower Atrium
11:00 AM - 1:00 PM Poster Setup Jefferson/ Lake/ Canyon Rooms
1:00 - 10:00 PM Poster Viewing Jefferson/ Lake/ Canyon Rooms
4:30 - 5:00 PM Coffee Available Lower Atrium
5:00 - 7:00 PM Novel Functions of Ubiquitin Gallatin/ Madison
* Simona Polo, FIRC Institute of Molecular Oncology
Russell A. DeBose-Boyd, University of Texas Southwestern Medical Center
Ubiquitination and Degradation of the Cholesterol Biosynthetic Enzyme, HMG CoA Reductase
Mark W. Hochstrasser, Yale University
Regulation of Ubiquitin Enzymes at the Endoplasmic Reticulum and Nuclear Envelope
Yinon M. Ben-Neriah, Hebrew University, Hadassah Medical School
Cell-Polarity Control of Protein Degradation in Intestinal Epithelial Cells
Peter Kaiser, University of California, Irvine
Short Talk: Proteolysis-Independent Regulation by Poly-Ubiquitination
7:00 - 8:00 PM Social Hour w/ Lite Bites Gallatin/Lake/Canyon Rooms
7:30 - 10:00 PM Poster Session 3 Jefferson/ Lake/ Canyon Rooms
Thursday, February 8
7:00 - 8:00 AM Breakfast Jefferson/ Lake/ Canyon Rooms
8:00 - 11:15 AM The Ubiquitin System: Disease and Drug Targets Gallatin/ Madison
* Thomas Sommer, Max Delbrück Center for Molecular Medicine
Tony Hunter, The Salk Institute
Crosstalk Between Phosphorylation and Sumoylation Pathways and Ubiquitination
Gentry N. Patrick, University of California, San Diego
UPS and Mammalian CNS Synapses
Ron R. Kopito, Stanford University
Protein Aggregation and Neurodegeneration
Laurent Coscoy, University of California, Berkeley
Ubiquitination on Non-lysine Residues
Agata M. Smogorzewska, Harvard Medical School, Massachusetts General Hospital
Short Talk: Cloning and Characterization of FANCI, a Novel Component of the Fanconi Anemia Pathway
Frédéric Colland, Hybrigenics
Short Talk: Identification and Characterization of Small Molecule Inhibitors of Ubiquitin-Specific Protease 8, a Newly Validated Cancer Target
9:20 - 9:40 AM Coffee Break Lower Atrium
4:30 - 5:00 PM Coffee Available Lower Atrium
5:00 - 7:00 PM Proteomics and Other Technology Trends Gallatin/ Madison
* William G. Kaelin Jr., Dana Farber Cancer Institute
Pharmacodynamic Imaging with Degron-Containing Luciferase Fusion Proteins
Steven P. Gygi, Harvard Medical School
Mass Spectrometry Based Methods for Analysis of Site Specific Ubiquitination
Dieter A. Wolf, Harvard School of Public Health
Systematic Screening for Ubiquitylation Substrates
Benjamin Nicholson, Progenra
Short Talk: Mining the Deubiquitinase Space with a Novel Reporter Assay
7:00 - 8:00 PM Social Hour w/ Lite Bites Jefferson/ Madison
8:00 - 11:00 PM Entertainment Jefferson/ Madison
Friday, February 9
Departure
*Session Chair   †Speaker invited, not yet responded.



© 2010 Keystone Symposia on Molecular and Cellular Biology. All Rights Reserved.
Terms of Use | Privacy Policy | Site Map

Keystone Symposia is a 501(c)(3) non-profit organization directed and supported by the scientific community.

Phone: +1 (800) 253-0685 or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org